These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22525603)

  • 1. Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development.
    Feng JQ; Mi JG; Wu L; Ma LW; Shi LJ; Yang X; Liu W; Zhang CP; Zhou ZT
    Oral Oncol; 2012 Sep; 48(9):848-52. PubMed ID: 22525603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus.
    Shi P; Liu W; Zhou ZT; He QB; Jiang WW
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):844-9. PubMed ID: 20200437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer.
    Feng JQ; Xu ZY; Shi LJ; Wu L; Liu W; Zhou ZT
    J Oral Pathol Med; 2013 Feb; 42(2):148-53. PubMed ID: 22725270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study.
    Liu W; Feng JQ; Shen XM; Wang HY; Liu Y; Zhou ZT
    Cancer; 2012 Mar; 118(6):1693-700. PubMed ID: 22009787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podoplanin and ABCG2 expression in oral erythroplakia revisited: Potential evidence for cancer stem cells driving the process of field cancerization.
    Yang X; Shi L; Zhou Z; Liu W
    Oral Oncol; 2020 Feb; 101():104368. PubMed ID: 31300272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
    Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
    J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma.
    Dalley AJ; Pitty LP; Major AG; Abdulmajeed AA; Farah CS
    Cancer Med; 2014 Apr; 3(2):273-83. PubMed ID: 24415717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podoplanin expression in oral leukoplakia: tumorigenic role.
    de Vicente JC; Rodrigo JP; Rodriguez-Santamarta T; Lequerica-Fernández P; Allonca E; García-Pedrero JM
    Oral Oncol; 2013 Jun; 49(6):598-603. PubMed ID: 23473850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
    Tarle M; Müller D; Raguž M; Lukšić I
    Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
    Tsunoda S; Okumura T; Ito T; Kondo K; Ortiz C; Tanaka E; Watanabe G; Itami A; Sakai Y; Shimada Y
    Oncology; 2006; 71(3-4):251-8. PubMed ID: 17671398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRIG1, human EGFR inhibitor, reverses multidrug resistance through modulation of ABCB1 and ABCG2.
    Liu B; Guo Z; Dong H; Daofeng T; Cai Q; Ji B; Zhang S; Wu L; Wang J; Wang L; Zhu X; Liu Y; Chen Q
    Brain Res; 2015 Jun; 1611():93-100. PubMed ID: 25801120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased oral availability and brain accumulation of the ALK inhibitor crizotinib by coadministration of the P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) inhibitor elacridar.
    Tang SC; Nguyen LN; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Int J Cancer; 2014 Mar; 134(6):1484-94. PubMed ID: 24037730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of ABCG2 and p-glycoprotein in residual breast cancer tissue after chemotherapy and their correlation with epithelial-mesenchymal transition].
    Qu H; Fang L; Duan L; Long X
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):236-40. PubMed ID: 24915813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of ATP-binding cassette transporter ABCG2 in gastric carcinoma and its significance].
    Wang N; Chen L; Wei B; Zhao XY; Lu WJ; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):450-3. PubMed ID: 17851787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival.
    Wang X; Xia B; Liang Y; Peng L; Wang Z; Zhuo J; Wang W; Jiang B
    Cancer Biomark; 2013; 13(2):81-8. PubMed ID: 23838136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
    Mizuarai S; Aozasa N; Kotani H
    Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of breast cancer resistance protein in acute lymphoblastic leukemia.
    Plasschaert SL; van der Kolk DM; de Bont ES; Kamps WA; Morisaki K; Bates SE; Scheffer GL; Scheper RJ; Vellenga E; de Vries EG
    Clin Cancer Res; 2003 Nov; 9(14):5171-7. PubMed ID: 14613996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx.
    Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H
    Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.